The Subsidiary Will Land On The Gem &Nbsp, And Earn Nearly 20 Times.

Last year, domestic listed companies were listed on the gem to be approved by regulators. After 10 months, the final announcement was made.

As early as last April 13th, the gem issued regulatory business communication.

It has undergone a gradual evolution of the equity capital of the company that gradually controlled its control.

In August 2003, Shanghai Industrial Union Pharmaceutical Co., Ltd. pferred its 23% stake in Zuoli pharmaceutical company to conbay, and in May 2004, it pferred 28% of its holdings to conbay.

Subsequently, Kang Bei Bei was granted the 6% stake of Zuoli pharmaceutical company owned by Beihu commerce and Rong Yi company respectively.

So far, he has brought the company to 63% of the total stake.

In order to meet the requirements of the main board to separate the listing of the gem, it began to gradually sell its control rights in 2007.

In November 2007, its pharmaceutical sales company pferred its 6% stake to 1 natural persons, who pferred 31% of its holdings to 30 natural persons.

At this point, he was relegated to the second largest shareholder.

According to the prospectus of Zuoli pharmaceutical, 15 million 600 thousand shares were held before the issue, and the proportion was 26%, and the proportion will be reduced to 19.5% after issuance.

In the light of the previous pfer prices in the disclosed share capital evolution, it is estimated that the cost of the shares is 19 million 130 thousand yuan.

In terms of the 23.5 yuan issue price, the 15 million 600 thousand stock market worth 367 million yuan.

Without considering the performance of the two tier market, the company has gained nearly 20 times its investment income.

CIC expects that in the next three years, the net profit growth of Zuoli pharmaceutical company will be at least 50%. According to the 40 times PE in 2011, its reasonable share price should be more than 40 yuan.

From this point of view, after the listing of Zuoli pharmaceutical, the market value of its holdings will continue to grow.

However, since January 26th, since the issuance of the letter of intent to offer shares, Zoe has increased by 10%, which is basically unchanged from the increase in the Shanghai index 8%.